Lung manifestation and pulmonary hypertension in systemic lupus erythematodes
نویسندگان
چکیده
منابع مشابه
Shrinking Lung Syndrome: A Pulmonary Manifestation of Systemic Lupus Erythematosus
Objectives: To describe the diurnal and nocturnal findings of 4 adults (3 women) and one child with systemic lupus erythematosus and shrinking lung syndrome. Design: A prospective observational study. Setting: A 750 teaching-bed-hospital with a reference population of 350,000 people. Interventions: Clinical history, blood analysis, imaging test, pulmonary function tests, maximal inspiratory and...
متن کاملClinical and preclinical manifestation of systemic lupus erythmatous
Introduction: Systemic lupus erythmatous (SLE) is a disease of unknown etiology with wide variety of clinical and immunological features. Our objective was to describe the clinical manifestation and laboratory data in Iranian male patients. Methods: 2279 patients were entered in a cross sectional study. The data were collected from rheumatologic research center in Shariati hospital of Teh...
متن کاملHematologic manifestation of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. The most common hematologic finding is anemia, leukopenia, thrombocytopenia and secondary antiphospholipid syndrome with recurrent abortion and thrombosis. The autoimmune fibrosis of bone marrow is another manifestation of autoimmune disease especially SLE, that must be correctly differentiated from primary myelofibrosis.
متن کاملAsymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
INTRODUCTION Pulmonary arterial hypertension (PAH) is a serious and often fatal complication of systemic lupus erythematosus (SLE). Because the diagnosis of PAH often is made years after symptom onset, early diagnostic strategies are essential. Doppler echocardiography currently is considered the noninvasive screening test of choice for evaluating pulmonary hypertension. AIM Screening for asy...
متن کاملPulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.
Pulmonary arterial hypertension (PAH) is a severe manifestation of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). Due to improvements in the understanding of the pathogenesis of these diseases, improved methodological rigour in the conduct of epidemiological studies and the advent of successful therapies, our understanding of SSc-PAH and SLE-PAH has evolved considerably. In th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Global Imaging Insights
سال: 2017
ISSN: 2399-7397
DOI: 10.15761/gii.1000130